Smith-Lemli-Opitz syndrome and Inborn Errors of Cholesterol Synthesis
Smith-Lemli-Opitz syndrome and Inborn Errors of Cholesterol Synthesis
批准号:
8458167
负责人:
Robert David Steiner
金额:
$2.75万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-03-08 至 2013-10-01
关键词:
AddressAnimalsAwardBiochemicalCholesterolCholesterol HomeostasisClinical InvestigatorDefectDisciplineDiseaseDisease modelEmbryonic DevelopmentFamilyFoundationsFunctional disorderFundingFutureGenotypeHereditary DiseaseInborn Genetic DiseasesInternationalJournalsMedicalMetabolismNational Heart, Lung, and Blood InstituteNational Institute of Child Health and Human DevelopmentNervous System PhysiologyNeuraxisPathogenesisPatientsPeer ReviewPhenotypePlayPublishingRare DiseasesResearchRoleRunningScheduleScientistSmith-Lemli-Opitz SyndromeSteroidsSterolsTherapeuticTherapeutic InterventionTimeTravelUnited States National Institutes of HealthWorkabstractingbaseimprovedmeetingsneurosteroidsnovel strategiesposterspublic health relevancesymposium
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): In June 2007, clinicians and scientists working on rare diseases caused by abnormal sterol metabolism organized a conference (Smith-Lemli-Opitz Syndrome and Inborn Errors of Cholesterol Synthesis) in Portland, OR. Since then, much progress has been made in the field of sterols and rare diseases so as to warrant another conference that will bring together scientists, clinical investigators, trainees and families. The overall objective of the proposed conference is to integrate the most up-to-date information from various research disciplines relevant to SLOS and help define future research directions. The major topics that will be covered during the conference include: 1) rare diseases caused by abnormal sterol metabolism; 2) role of sterols in embryonic development and central nervous system function; 3) pathogenesis of SLOS and other sterol-related genetic diseases; 4) relevant animal and cellular disease models; 5) from genotype to phenotype; and 6) perspective on therapeutics. The proceedings of the Conference will be published in a peer-reviewed journal. The 2013 SLOS Scientific Conference will be held in June 2013 in Pittsburgh, PA. The Conference will be in the form of a symposium with significant time allocated for discussion periods following introductory and scientific talks. National and international experts in relevant
fields will be invited. Young scientists and trainees will be encouraged to attend and present their work at a poster session. Travel awards will be made based on meritorious abstract submissions. Importantly, the Conference will be held in conjunction with the SLO/RSH Family and Medical biannual meeting. A Q & A session will be organized the agenda will allow several opportunities for direct interactions between families and scientists.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of N-tert-(Butyl)hydroxylamine (NtBuHA) as a therapeutic agent for treating Infantile Neuronal Ceroid Lipofuscinosis (INCL)
-
批准号:10325237
-
项目类别:
-
资助金额:$144.18万
-
财政年份:2021
-
负责人:Robert David Steiner
-
依托单位:
Antioxidant Therapeutic Clinical Trial in Smith-Lemli-Opitz Syndrome
-
批准号:8332317
-
项目类别:
-
资助金额:$53.63万
-
财政年份:2011
-
负责人:Robert David Steiner
-
依托单位:
Antioxidant Therapeutic Clinical Trial in Smith-Lemli-Opitz Syndrome
-
批准号:8153405
-
项目类别:
-
资助金额:$13.0万
-
财政年份:2010
-
负责人:Robert David Steiner
-
依托单位:
Antioxidant Therapeutic Clinical Trial in Smith-Lemli-Opitz Syndrome
-
批准号:8130792
-
项目类别:
-
资助金额:$68.79万
-
财政年份:2010
-
负责人:Robert David Steiner
-
依托单位:
Sterol and Isoprenoid Diseases Consortium
-
批准号:8151621
-
项目类别:
-
资助金额:$13.0万
-
财政年份:2009
-
负责人:Robert David Steiner
-
依托单位:
Antioxidant Therapeutic Clinical Trial in Smith-Lemli-Opitz Syndrome
-
批准号:7937399
-
项目类别:
-
资助金额:$89.96万
-
财政年份:2009
-
负责人:Robert David Steiner
-
依托单位:
Sterol and Isoprenoid Diseases Consortium
-
批准号:8130793
-
项目类别:
-
资助金额:$55.33万
-
财政年份:2009
-
负责人:Robert David Steiner
-
依托单位:
Sterol and Isoprenoid Diseases Consortium
-
批准号:7941762
-
项目类别:
-
资助金额:$55.79万
-
财政年份:2009
-
负责人:Robert David Steiner
-
依托单位:
Sterol and Isoprenoid Diseases Consortium
-
批准号:7680784
-
项目类别:
-
资助金额:$89.96万
-
财政年份:2009
-
负责人:Robert David Steiner
-
依托单位:
Dietary Cholesterol and Defects in Cholesterol Synthesis
-
批准号:6926171
-
项目类别:
-
资助金额:$44.01万
-
财政年份:2003
-
负责人:Robert David Steiner
-
依托单位:
CLINICAL ASPECTS OF C2 AUC PROFILING TO ASSESS NEORAL EXPOSURE
-
批准号:7205649
-
项目类别:
-
资助金额:$3.97万
-
财政年份:2003
-
负责人:Robert David Steiner
-
依托单位:
Dietary Cholesterol and Defects in Cholesterol Synthesis
-
批准号:8072702
-
项目类别:
-
资助金额:$49.83万
-
财政年份:2003
-
负责人:Robert David Steiner
-
依托单位:
Dietary Cholesterol and Defects in Cholesterol Synthesis
-
批准号:7092983
-
项目类别:
-
资助金额:$45.24万
-
财政年份:2003
-
负责人:Robert David Steiner
-
依托单位:
Dietary Cholesterol and Defects in Cholesterol Synthesis
-
批准号:8288749
-
项目类别:
-
资助金额:$51.66万
-
财政年份:2003
-
负责人:Robert David Steiner
-
依托单位:
Dietary Cholesterol and Defects in Cholesterol Synthesis
-
批准号:8478164
-
项目类别:
-
资助金额:$42.45万
-
财政年份:2003
-
负责人:Robert David Steiner
-
依托单位:
Dietary Cholesterol and Defects in Cholesterol Synthesis
-
批准号:7392035
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2003
-
负责人:Robert David Steiner
-
依托单位:
C2 AUC Profiling to Assess Neoral Exposure
-
批准号:7045482
-
项目类别:
-
资助金额:$1.59万
-
财政年份:2003
-
负责人:Robert David Steiner
-
依托单位:
Dietary Cholesterol and Defects in Cholesterol Synthesis
-
批准号:6671732
-
项目类别:
-
资助金额:$26.92万
-
财政年份:2003
-
负责人:Robert David Steiner
-
依托单位:
Dietary Cholesterol and Defects in Cholesterol Synthesis
-
批准号:6793582
-
项目类别:
-
资助金额:$42.22万
-
财政年份:2003
-
负责人:Robert David Steiner
-
依托单位:
Dietary Cholesterol and Defects in Cholesterol Synthesis
-
批准号:7728895
-
项目类别:
-
资助金额:$51.33万
-
财政年份:2003
-
负责人:Robert David Steiner
-
依托单位:
海外基金